Akums Drugs and Pharmaceutical, a Delhi-based company, reported a 16% rise in profits compared to the same period last year. The company achieved this through improved operational efficiency. However, revenue decreased by 11.9% due to lower prices of active pharmaceutical ingredients and fluctuating demand.
from Stocks-Markets-Economic Times https://ift.tt/h1zMw3v
Akums Drugs adj. net profit rises 16% YoY to Rs 66.7 crore in Q2FY25
Related Posts:
NSE-BSE bulk deals: Acacia Conservation Fund sells stake in ESAB India- Ahead of Market: 12 things that will decide stock action on Thursday
- Oyo adds 20 cr shares to existing ESOP pool, expands employee stock options to 63 cr shares
- Sebi proposes to revise settlement rules
- Temasek in advanced talks for 40% stake in True North-owned Integrace
0 Comments:
Post a Comment